Monday, May 11, 2026
Home Blog Page 167

The Digital Trap: How Screens Are Luring Youth into a Dark Abyss

0

The digital world beckons today’s youth with an irresistible glow — endless streams of likes, viral challenges, and instant connections. Yet beneath this facade lies a predatory mechanism that preys on developing minds, drawing young people into a realm of addiction, isolation, and psychological torment from which escape feels impossible. Social media platforms and tech giants have engineered algorithms that exploit human vulnerabilities, turning curiosity into compulsion and self‑worth into a metric of engagement. The consequences are not mere inconveniences; they are a generation teetering on the edge of irreversible harm.

Social media’s grip on teenagers is particularly vicious. A Child Mind Institute analysis reveals how platforms like Instagram and TikTok amplify body image distortions, especially among girls, where exposure to filtered “fitspiration” content correlates strongly with dissatisfaction and disordered eating. Boys face parallel pressures through hyper‑masculine ideals. These apps do not merely reflect societal standards; they curate and intensify them, flooding feeds with algorithmically selected content that triggers comparison and despair. Studies link heavy use to a weak but significant rise in depression symptoms, with problematic patterns — endless scrolling or doomscrolling — posing the greatest risk. The result? Teens who once played outside now measure their value by likes, retreating into echo chambers that warp reality.

Education, once a sanctuary for growth, has become another battleground. Technology’s infiltration promises personalization but delivers distraction. Educatly outlines how notifications, games, and multitasking fragment attention, reducing deep learning and critical thinking. Students glued to screens during lessons multitask compulsively, academic performance plummets, and focus spans shrink. Overreliance breeds helplessness: when Google supplies instant answers, why wrestle with problems? This erodes resilience, leaving youth ill‑equipped for real‑world challenges. The digital divide compounds the crisis — low‑income students lack devices or bandwidth, widening gaps while affluent peers drown in options. Face‑to‑face interactions fade, replaced by shallow chats, stunting empathy and social skills essential for adulthood.

Physical and mental health tolls mount relentlessly. Medical News Today documents eyestrain, neck pain, and sleep disruption from blue light and late‑night scrolling, with the 20‑20‑20 rule (every 20 minutes, look 20 feet away for 20 seconds) offered as a futile Band‑Aid. Sedentary habits fuel obesity, while sedentary screen time displaces exercise. Psychologically, the damage runs deeper: problematic use triples social isolation risks, fostering anxiety and desensitization to violence via algorithmically amplified graphic content. Deepfakes and cyberbullying erode trust, blurring truth from fabrication. A PMC review on over‑reliance warns of “automation bias,” where youth blindly trust tech outputs, surrendering agency to flawed AI that reinforces biases and complacency.

This is no accident. Tech companies prioritise engagement over well‑being, designing addictive loops that mimic slot machines — variable rewards keep users hooked. The PMC article likens it to handing responsibility to systems that fail silently, fostering errors of omission when alerts miss real dangers. Youth, with brains wired for novelty and peer approval, are most susceptible. What starts as harmless fun spirals into a dark side: cyber addiction, where dopamine hits from notifications override real relationships; identity crises from curated personas; and a feedback loop of misinformation that hardens extremes.

The escape routes narrow daily. Algorithms personalise the trap, feeding users more of what keeps them scrolling — outrage, envy, fantasy. Parents and schools, outpaced by rapid evolution, struggle with enforcement. Bans feel draconian; moderation impossible. Policymakers debate regulation, but global platforms evade accountability, lobbying against age gates or time limits. By the time awareness dawns — through burnout, breakdowns, or regret — neural pathways may be rewired for dependency. Studies show heavy users exhibit brain changes akin to substance addiction, with withdrawal triggering irritability and anxiety.

Africa’s youth face amplified perils. Rapid smartphone penetration outstrips digital literacy, exposing millions to unfiltered toxicity amid economic pressures. In Ethiopia, where mobile money and social media boom, teens juggle studies with viral fame dreams, often at mental health’s expense. Global data applies locally: rising depression, self‑harm ideation, and suicides trace to online pressures.

Yet glimmers of resistance exist. Parents must reclaim evenings with device‑free zones and model offline joys. Schools can integrate media literacy, teaching discernment over immersion. Tech firms bear moral weight: transparency in algorithms, default safeguards for minors, and profit models beyond addiction. Governments need spine — enforce age verification, tax predatory engagement, fund mental health nets.

The digital world’s allure is a siren call, luring youth to a shadow realm of fractured psyches and stunted potential. Without collective intervention, this generation risks emerging hollow — connected yet alone, informed yet deceived, alive yet diminished. The dark side beckons not with malice, but with the false promise of belonging. We must pull them back before the door slams shut.

Italian Charities Partner with Ethiopian Foundation to Fund Free Heart Surgeries for 50 Children

0

The Heart to Heart Children’s Charity Foundation, an Ethiopia-based organisation registered in the United States, has signed a landmark cooperation agreement with three leading Italian charities to provide free heart surgeries for 50 children at Ethio-Istanbul General Hospital in Addis Ababa.

The agreement, reached with Una per Voce Padre Pio, CCPM and REBEL Hearts, addresses Ethiopia’s critical shortage of paediatric cardiology services. Enzo Palumbo, who leads the Italian organisations, committed to ongoing support beyond one-time aid during a recent visit to the hospital.

“Our mission goes beyond surgery — we aim to build a lasting bridge in medical care,” Mr. Palumbo said. “Twice yearly, we will send 17 senior specialists — surgeons, anesthesiologists, cardiologists and intensive care nurses — to ensure Ethiopian children receive world-class treatment at home.”

The partnership follows a multi-year collaboration model, targeting 50 children per visit and 100 annually. Beyond surgeries, it includes supplying medical equipment and transferring expertise to local staff at Ethio-Istanbul Hospital. The first medical campaign launches in April 2018 E.C. (2026 G.C.), with the Italian team bringing all necessary resources.

Marking the occasion during Ethiopia’s holiday season, the 50 children selected for April surgeries received “Christmas Gift Certificates” guaranteeing free treatment — a profound relief for families long burdened by prohibitive costs and travel.

Berhan Tedla, founder of Heart to Heart and owner of Ethio-Istanbul General Hospital, highlighted the toll of untreated heart disease. “Many children die waiting for timely care. This partnership is a lifeline for desperate families,” he said.

Since opening, Ethio-Istanbul has already treated over 85 children with heart conditions, though Berhan stressed the problem’s vast scale requires stronger government support, including from the Ministry of Health.

The agreement positions Ethiopia as a regional hub for specialised paediatric care while easing the medical tourism drain that costs the country hundreds of millions annually in foreign currency. Italian and Ethiopian partners pledged to scale the model, combining philanthropy, expertise transfer and local capacity-building to save more young lives.

Name | Shewalem Taju

0

Education (የት/ት ደረጃ):

 Diploma

 Company name (የመስሪያ ቤቱ ስም):

 Shewa Spices

 Title (የስራ ድርሻ):

 Manager

 Founded in (መቼ ተመሰረተ):

  2024

 What it does (ምንድነው የሚሰራው):

Preparing a variety of homemade spices

 Headquarters (ዋና መስሪያ ቤት):

 Online-Based

 Start-up capital (በምን ያህል ገንዘብ ስራዉን ጀመርክ):

   30,000 Birr

 Current capital (የአሁን ካፒታል):

  Growing

 Number of employees (የሰራተኞች ቁጥር):

   3

 Reason for starting the business (ለስራው መጀመር ምክንያት):

 Desire to provide healthy and clean national cultural dishes

 Biggest perk of ownership (የባለቤትነት ጥቅም):

Keeping my head up on my own

 Biggest strength (ጥንካሬህ):

  Diligence and quality

 Biggest challenge (ተግዳሮት):

Raw materials quality

 Plan (እቅድ):

To become a well-known spice brand

 First career path (የመጀመሪያ ስራ):

  Hotel manager

 Most interested in meeting (ማግኘት የምትፈልገው ሰው):

  None

 Most admired person (የምታደንቀው ሰው):

  My Wife

 Stress reducer (ጭንቀትን የሚያቀልልህ):

  Listening music

 Favorite book (የመፅሐፍ ምርጫ):

   Qur’an

 Favorite pastime (ማድረግ የሚያስደስትህ):

  Trying new types of food

 Favorite destination to travel to (ከኢትዮጵያ ውጪ መሄድ የምትፈልገው ስፍራ):

   Dubai

 Favorite automobile (የመኪና ምርጫ):

   Toyota Vitz

The Future can be Bright in the fight against TB

0

As we start the new year, contrary to what you may have heard, Africa can build off of significant progress against a disease that has long plagued it – tuberculosis (TB). According to the World Health Organization’s annual report on TB, in 2024, estimated numbers of new cases continue to decline in sub-Saharan Africa, while efforts to detect new cases continue to gain traction.

As a result, the estimates of undiagnosed cases have shrunk every year for the past decade. Mortality rates have also declined steeply over the past 10 years for both HIV-positive and -negative people – the only region in the world where this trend has been seen.

Some of the African countries with the worst burdens of disease have seen the most consistent progress. Every year since 2020, Central African Republic (CAR), Democratic Republic of Congo (DRC) and Kenya have all seen their TB case detections increase while overall incidence has declined. CAR, DRC, Liberia, Nigeria and Sierra Leone have all seen TB deaths decrease annually in that same timespan. And, also every year since 2020, Angola, DRC, Nigeria, Somalia, South Africa, Zambia, Zimbabwe—all countries with a high burden of drug-resistant TB (DR-TB)—have seen the number of new DR-TB cases drop.

In November, my own organization, TB Alliance, released promising Phase 2 clinical trial results on a new TB treatment regimen—one that includes an experimental compound, sorfequiline. The regimen could place us on a path to develop a TB treatment that could potentially last only one month, an innovation in TB care allowing us to imagine a world where TB can be not just “controlled,” but truly eradicated.

And yet, much of this good news has been overlooked in the turmoil generated by steep cuts in foreign aid by traditional donor countries. To be clear, these cuts have had severe impacts, especially in sub-Saharan Africa where many diseases still hit hard. Despite the progress we’ve achieved, 25 out of the 47 countries in our region still have a high burden of TB, drug-resistant TB, or TB-HIV co-infections. Reduced funding, at the very least, slows our pace in turning the tide.

Unfortunately, financial adversities in the fight against TB have long been part of our challenge. The fact there are still more than 10 million TB cases yearly and 1.2 million deaths is evidence that the world has never mounted a TB response in scope or urgency that is proportionate to the health and financial impact of the disease.

Despite such challenges, the TB community has showed incredible resiliency and efficiency, and has made tremendous progress – even after experiencing significant setbacks due to the COVID-19 pandemic, when many TB research labs and treatment facilities had to rapidly pivot to serve as key contributors to the COVID-19 response.

Two key drivers of this progress have been increased national commitments to prioritize combatting TB and the rapid adoption of new TB technologies.

South Africa is an example of what national vision, leadership and investment can achieve. It is one of the world’s leaders in rapidly and widely adopting new, shorter treatments for DR-TB. South Africa has about 80% of people with DR-TB on BPaL-based treatment and the country plans to treat about 90% with these regimens in the next year. And, with a new TB dashboard tracking its progress in testing 5 million people before 2035, it is showing transparency and accountability in achieving bold TB goals.

Nigeria is another great example, working diligently to not just identify new DR-TB cases but also to secure the new treatments that can have such a marked impact on a disease that once required a year and a half of harsh medicines. Today, Nigeria already has more than 90% of people with DR-TB being treated with the BPaL/M regimens.

Regardless of international investment, the urgency behind the goal of ending TB can be found at home. High-burden countries have an opportunity to lead the way, leveraging the progress from the past five years, and to make a real difference in improving the lives of communities by investing in TB control and research. TB preys on the least wealthy communities; solving the disease requires governments to invest in and lift up these communities. When we see this in action, we empower ourselves to shed the weight of a TB pandemic and create new opportunities for health and wealth.

We will not learn about the numbers for 2025 until the end of this year, but as long as governments continue this work, we can be confident that the momentum can continue.

For those who doubt this scenario, consider this – research is continuing. Even as my organization prepares for a Phase 3 clinical trial that will include sorfequiline and the new experimental regimen that would yield more new treatment tools, other research is continuing. More innovative technologies will be arriving because the scientific community is just as determined to end TB once and for all. And, as 2026 kicks off, that is something we can all be grateful for.

Dr. Morounfolu (Folu) Olugbosi works with the clinical development of products in TB Alliance’s research portfolio, helps to oversee clinical trials in TB endemic countries, and heads the organization’s South Africa office.